ArticleBMC cardiovascular disorders2025
Serum endotrophin relates to blood pressure in young South Asian women but not White women: evidence of ethnic variation in its early vascular implications.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic, viral, and immune phenotypes in long COVID.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundEndotrophin is a novel circulating fibroinflammatory protein that has recently been associated with cardiovascular disease (CVD) and all-cause mortality. However, little is known about its role early in the natural history of vascular disease nor whether it exhibits ethnicity-specific variation. Recognizing that South Asians have an elevated risk of ultimately developing CVD, we sought to address these questions by characterizing endotrophin and its physiologic correlates in young South Asian women as compared to White women.
methodsFrom a cohort recruited in pregnancy and followed to 1-year after delivery, we identified 40 participants of South Asian descent and 40 age- and BMI-matched White women. These individuals underwent cardiometabolic characterization at 1-year postpartum, including assessment of anthropometrics, blood pressure, glucose tolerance, insulin resistance, pancreatic beta-cell function, and serum endotrophin.
resultsThere was no significant difference in serum endotrophin concentration between South Asians and Whites (median 19.3 ng/ml [interquartile range 14.5-23.8] vs 17.3 ng/ml [14.4-21.7], p = 0.37). However, endotrophin was positively correlated with systolic blood pressure (r = 0.43, p = 0.006) in South Asians but not in White women (r = -0.02, p = 0.89), mirroring differential associations that were similarly observed with fasting glucose (South Asian: r = 0.34, p = 0.03; White: r = -0.21, p = 0.21). Moreover, on multiple linear regression analyses, systolic blood pressure was independently associated with endotrophin in South Asians only (beta = 0.016, p = 0.008).
conclusionEndotrophin relates to blood pressure in young South Asian women but not White women, suggesting ethnic variation in its early vascular associations that potentially could be relevant to the elevated lifetime risk of CVD in South Asians.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.